Moberg Pharma AB (publ) (STO:MOB)

Moberg Pharma AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-254.73	-255.11	-21.09	-15.71	7.49	5.87
Depreciation & Amortization	301.46	301.32	2.1	2.58	2.58	2.52
Stock-Based Compensation	5.91	4.72	2.31	1.46	0.63	0.95
Other Operating Activities	-66.35	-65.36	-4.36	-3.8	-27.46	2.79
Change in Accounts Receivable	1.56	-0.71	0.42	-0.21	6.84	-2.79
Change in Inventory	-2.59	2.82	-7.12	-	-	-
Change in Other Net Operating Assets	1.13	-4.14	-5.46	-1.16	-4.99	-18.43
Operating Cash Flow	-13.61	-16.47	-33.21	-16.84	-15.3	-10.41
Cash Acquisitions	-	-	-	-	-10	-2.51
Sale (Purchase) of Intangibles	-65.94	-73.55	-124.12	-68.07	-31.31	-41.42
Investing Cash Flow	-65.94	-73.55	-124.12	-68.07	-41.31	-43.93
Long-Term Debt Repaid	-	-1.39	-2.43	-1.87	-3.46	-
Total Debt Repaid	-1.43	-1.39	-2.43	-1.87	-3.46	-18.17
Net Debt Issued (Repaid)	-1.43	-1.39	-2.43	-1.87	-3.46	-18.17
Issuance of Common Stock	21.15	335.52	100.64	109.68	133.44	37.54
Repurchase of Common Stock	-	-	-0.19	-	-	-558.27
Other Financing Activities	-11.38	-11.38	-5.7	-	-	-
Financing Cash Flow	8.34	322.76	92.33	107.81	129.97	-538.89
Net Cash Flow	-71.21	232.73	-65	22.9	73.37	-593.23
Free Cash Flow	-13.61	-16.47	-33.21	-16.84	-15.3	-10.41
Free Cash Flow Margin	-110.21%	-167.87%	-	-8136.23%	-	-30.93%
Free Cash Flow Per Share	-0.29	-0.43	-2.09	-2.22	-3.55	-5.50
Cash Interest Paid	0.23	0.23	0.26	0.07	0.24	2.07
Levered Free Cash Flow	44.22	27.25	-149.44	-65.28	40.32	-
Unlevered Free Cash Flow	44.35	27.4	-149.28	-65.24	40.4	-
Change in Working Capital	0.1	-2.03	-12.16	-1.37	1.85	-21.21

Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.